Aratana Therapeutics Inc
Change company Symbol lookup
Select an option...
PETX Aratana Therapeutics Inc
TI Telecom Italia SpA
RM Regional Management Corp
BAC Bank of America Corp
GSPH Geospatial Corp
SLV iShares Silver Trust
STOR Store Capital Corp
GLU Gabelli Global Utility & Income Trust
XLB Materials Select Sector SPDR® Fund
XLF Financial Select Sector SPDR® Fund
Go

Health Care : Pharmaceuticals | Small Cap GrowthCompany profile

Aratana Therapeutics, Inc. is a pet therapeutics company focused on licensing, developing and commercializing of biopharmaceutical products for companion animals. The Company's portfolio includes therapeutic candidates in development consisting of small molecule pharmaceuticals and large molecule biologics that target medical conditions in pets. Its lead product candidates in development include small molecules directed at treating osteoarthritis pain and inflammation (AT-001 for dogs, also known as grapiprant for dogs or GALLIPRANT), appetite stimulation (AT-002 for dogs, also known as capromorelin for dogs or ENTYCE) and post-operative pain (AT-003 for dogs, also known as bupivacaine liposome injectable suspension for dogs or NOCITA). AT-001 is a selective antagonist of the prostaglandin E2 (PGE 2) EP4 receptor (EP4 prostaglandin receptor antagonist or EP4 PRA). AT-002 is a potent and selective ghrelin agonist. Its product candidates also include AT-014, AT-016 and AT-018 for dogs.

Closing Price
$4.42
Day's Change
0.28 (6.76%)
Bid
--
Ask
--
B/A Size
--
Day's High
4.47
Day's Low
3.98
Volume
(Heavy Day)
Volume:
4,977,221

10-day average volume:
1,811,773
4,977,221
  • Prev Close
    4.14
  • Today's Open
    4.20
  • Day's Range
    3.98-4.47
  • Avg Vol (10-day)
    1.8M
  • Last (time)
    3:59p ET 01/18/19
  • Last (size)
    756
  • 52-Wk Range
    3.67 - 7.16
    LowHigh
  • (03/15/18 - 11/08/18)
    20.44%
  • 55.3%
  • Market Cap
    214.9M
  • Shares Outstanding
    48.6M
  • -0.51
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.6
  • 60.96
  • (% of float 12/31/18)
    3.86

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.